• The results are being filtered by the character: A
A B C D E F G H J K L M N O P R S T U W X Y Z
Photo of Lauren Aleksunes Pharm.D., Ph.D., D.A.B.T.
Lauren Aleksunes, Pharm.D., Ph.D., D.A.B.T.
Professor – Pharmacology and Toxicology Ernest Mario School of PharmacyEOHSI – Toxicology Division

Lauren Aleksunes’Lab 

Recent Publications

  1. Kinkade, CW, Brinker, A, Buckley, B, Waysack, O, Fernandez, ID, Kautz, A, Meng, Y, Shi, H, Brunner, J, Ohman-Strickland, P et al.. Sociodemographic and dietary predictors of maternal and placental mycoestrogen concentrations in a US pregnancy cohort. J Expo Sci Environ Epidemiol. 2024; :. doi: 10.1038/s41370-024-00722-6. PubMed PMID:39363096
  2. Taylor, R, Basaly, V, Kong, B, Yang, I, Brinker, AM, Capece, G, Bhattacharya, A, Henry, ZR, Otersen, K, Yang, Z et al.. Effects of Therapeutically Approved Individual Bile Acids on The Development of Metabolic Dysfunction-Associated Steatohepatitis a Low Bile Acid Mouse Model. Toxicol Sci. 2024; :. doi: 10.1093/toxsci/kfae110. PubMed PMID:39302723
  3. Aleksunes, LM, Gray, JP, Meshanni, J, Laskin, JD, Laskin, DL. Repurposing FDA-approved drugs to treat chemical weapon toxicities: Interactive case studies for trainees. Pharmacol Res Perspect. 2024;12 (4):e1229. doi: 10.1002/prp2.1229. PubMed PMID:38965070 PubMed Central PMC11223991
  4. Wen, X, Doherty, C, Thompson, LE, Kim, C, Buckley, BS, Jaimes, EA, Joy, MS, Aleksunes, LM. Determination of unbound platinum concentrations in human plasma using ultrafiltration and precipitation methods. J Pharmacol Toxicol Methods. 2024;128 :107535. doi: 10.1016/j.vascn.2024.107535. PubMed PMID:38955285
  5. Kinkade, CW, Aleksunes, LM, Brinker, A, Buckley, B, Brunner, J, Wang, C, Miller, RK, O’Connor, TG, Rivera-Núñez, Z, Barrett, ES et al.. Associations between mycoestrogen exposure and sex steroid hormone concentrations in maternal serum and cord blood in the UPSIDE pregnancy cohort. Int J Hyg Environ Health. 2024;260 :114405. doi: 10.1016/j.ijheh.2024.114405. PubMed PMID:38878407 PubMed Central PMC11441442
  6. Gutgarts, V, Gerardine, S, Shingarev, RA, Knezevic, A, Zabor, EC, Latcha, S, Joy, MS, Aleksunes, LM, Jaimes, EA. Evaluation of Cisplatin-Induced Acute Kidney Injury in Patients Coprescribed Serotonin Receptor Antagonists: A Retrospective Analysis. Kidney360. 2024;5 (8):1094-1100. doi: 10.34067/KID.0000000000000464. PubMed PMID:38814726 PubMed Central PMC11371355
  7. Chung, E, Wen, X, Jia, X, Ciallella, HL, Aleksunes, LM, Zhu, H. Hybrid non-animal modeling: A mechanistic approach to predict chemical hepatotoxicity. J Hazard Mater. 2024;471 :134297. doi: 10.1016/j.jhazmat.2024.134297. PubMed PMID:38677119 PubMed Central PMC11519847
  8. Galetin, A, Brouwer, KLR, Tweedie, D, Yoshida, K, Sjöstedt, N, Aleksunes, L, Chu, X, Evers, R, Hafey, MJ, Lai, Y et al.. Membrane transporters in drug development and as determinants of precision medicine. Nat Rev Drug Discov. 2024;23 (4):255-280. doi: 10.1038/s41573-023-00877-1. PubMed PMID:38267543 PubMed Central PMC11464068
  9. Kozlosky, D, Doherty, C, Buckley, B, Goedken, MJ, Miller, RK, Huh, DD, Barrett, ES, Aleksunes, LM. Fetoplacental Disposition and Toxicity of Cadmium in Mice Lacking the Bcrp Transporter. Toxicol Sci. 2023;197 (2):132-46. doi: 10.1093/toxsci/kfad115. PubMed PMID:37941438 PubMed Central PMC10823776
  10. Zhang, R, Walker, L, Wen, X, Doherty, C, Gorczyca, L, Buckley, B, Barrett, ES, Aleksunes, LM. Placental BCRP transporter reduces cadmium accumulation and toxicity in immortalized human trophoblasts. Reprod Toxicol. 2023;121 :108466. doi: 10.1016/j.reprotox.2023.108466. PubMed PMID:37660740 PubMed Central PMC10591833
Search PubMed
Photo of Tracy Anthony Ph.D.
Tracy Anthony, Ph.D.
Professor EOHSI Division of ToxicologySchool of Environmental and Biological Sciences

Research Interests

The Anthony Lab studies homeostatic responses to changes in nutrient supply and environmental stress. Our experiments aim to identify dietary components and cellular processes that prevent and treat serious diseases and promote healthspan. Over the years my group has published numerous high impact publications which delineate mechanisms of metabolic and proteostasis control by diet, drugs, genetics and environmental stressors. These works have spanned many organ systems including endocrine, gastrointestinal, hepatobiliary, immune, lymphatic, muscular and the central nervous system. With respect to diet and nutrient supply, we study how amino acid insufficiency or imbalance alters tissue proteostasis in the whole animal. We use experimental models that alter amino acid availability and work to understand how altering the supply of amino acids, in total or individually, is sensed and communicated under different metabolic states. We also are interested in metabolic and molecular responses to exercise and the crosstalk between diet and physical activity. Current projects in the laboratory may be grouped into the following areas:

Homeostatic responses to amino acid insufficiency

Alterations in amino acid availability and balance are sensed by overlapping signal transduction cascades. Two major signaling nodes responsive to amino acid supply in mammals are the: 1) Integrated Stress Response (ISR), also called the Amino Acid Response (AAR) and 2) mechanistic Target Of Rapamycin Complex 1 (mTORC1) pathway. While the mTORC1 pathway functions as a sensor of amino acid abundance to stimulate growth, the ISR/AAR is activated by amino acid deprivation to slow growth and instead favor cytoprotective and adaptive processes. How these signaling pathways work together to regulate gene-specific translation and promote cellular resilience is a major research focus of the lab. This project uses genetic strains of mice with targeted deficiencies in the ISR/AAR in combination of sophisticated molecular biology and stable isotope techniques to assess control of proteostasis and metabolism in tissues of mice.

Mechanisms of toxicity by asparaginase

Asparaginase is an important part of the remission induction regimen for treating acute lymphoblastic leukemia, the most common childhood cancer. The enzyme breaks down circulating asparagine and glutamine, creating a physiologically relevant model of amino acid deficiency. In leukemic cells which express very little asparagine synthetase (the enzyme that makes asparagine), asparaginase inflicts a lethal amino acid starvation. Yet for reasons not completely understood, cancer patients may unpredictably suffer severe complications, such as thromboembolism, liver failure and pancreatitis. Our lab was the first to report that phosphorylation of the translation factor, eIF2, by the amino acid sensor, GCN2, is activated by asparaginase. We were also the first to describe the ISR as the body’s first responder to asparaginase exposure. Since then we have gone on to show the impact of obesity and age on liver responses to asparaginase and we continue to use this agent as a research tool and study it to improve its efficacy to treat cancer and other diseases. This project utilizes a combination of biochemical, dietary, metabolic and molecular approaches in mice to identify mechanisms by which asparaginase causes metabolic complications and cell death. These results will be used to increase the safety and efficacy of asparaginase and to develop improved personalized approaches to the treatment of serious diseases.

ER stress and the Unfolded Protein Response

Chemical, environmental or nutritional perturbations that disrupt homeostasis within the endoplasmic reticulum (ER) activate a mechanism called the Unfolded Protein Response (UPR, also called the ER Stress Response). Phosphorylation of the translation factor eIF2 by PERK constitutes one arm of the UPR which serves to alleviate cell stress and re-establish homeostasis through a reprogramming of gene expression driven by the transcription factor ATF4. My laboratory is interested in exploring how the PERK-eIF2-ATF4 arm of the UPR contributes to the overall cellular effort to promote cellular adaptation and survival in response to a wide variety of environmental insults and proteotoxic stress agents.

Dietary protein, exercise, muscle growth and metabolic homeostasis

The interface of dietary protein and exercise as it relates to optimization of lean body mass is a longstanding area of interest and study. Previous projects in the lab include identifying metabolic and transcriptional signatures in the muscle of exercised horses, and varying the composition, distribution, source and/or timing of dietary protein on mTORC1 signaling and protein synthesis in mice. Information gained in this area will be targeted to relevant populations to improve performance and promote recovery and resilience.

 

170 Frelinghuysen Road, Piscataway, NJ 08854 – 848-445-0200  Fax: 732-445-0131

Copyright © 2021, Rutgers, The State University of New Jersey